Discovery of (R)-7-cyano-2,3,4, 5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3- (phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine (BMS-214662), a farnesyltransferase inhibitor with potent preclinical antitumor activity (Q31445193)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discovery of (R)-7-cyano-2,3,4, 5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3- (phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine (BMS-214662), a farnesyltransferase inhibitor with potent preclinical antitumor activity |
scientific article |
Statements
1 reference
Discovery of (R)-7-cyano-2,3,4, 5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3- (phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine (BMS-214662), a farnesyltransferase inhibitor with potent preclinical antitumor activity (English)
1 reference
Hunt JT
1 reference
Ding CZ
1 reference
Batorsky R
1 reference
Bednarz M
1 reference
Bhide R
1 reference
Cho Y
1 reference
Chong S
1 reference
Chao S
1 reference
Gullo-Brown J
1 reference
Guo P
1 reference
Kim SH
1 reference
Lee FY
1 reference
Leftheris K
1 reference
Miller A
1 reference
Mitt T
1 reference
Patel M
1 reference
Penhallow BA
1 reference
Ricca C
1 reference
Rose WC
1 reference
Schmidt R
1 reference
Slusarchyk WA
1 reference
Vite G
1 reference
Manne V
1 reference
1 reference
Identifiers
1 reference